Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Monte Rosa Therapeutics, Inc.(GLUE) | 5,652,922 | 4,382,687 | -1,270,235 | 41,888 | 68,721 | 45.49% | +26,832 |
| Jade Biosciences, Inc. | 1,525,820 | 1,525,820 | 0 | 13,168 | 23,543 | 15.59% | +10,376 |
| Contineum Therapeutics, Inc. | 542,628 | 542,628 | 0 | 6,376 | 6,202 | 4.11% | -174 |
| CRISPR Therapeutics AG(CRSP) | 148,831 | 148,831 | 0 | 9,646 | 7,805 | 5.17% | -1,841 |
| Tempest Therapeutics, Inc. | 269,772 | 269,772 | 0 | 2,773 | 774 | 0.51% | -1,999 |
| Adverum Biotechnologies, Inc. | 506,821 | 0 | -506,821 | 2,296 | 0 | — | -2,296 |
| Repare Therapeutics, Inc. | 2,646,657 | 0 | -2,646,657 | 4,658 | 0 | — | -4,658 |
| Skye Bioscience, Inc. | 2,007,704 | 2,007,704 | 0 | 7,890 | 1,505 | 1.00% | -6,385 |
| Lenz Therapeutics, Inc. | 2,656,888 | 2,656,888 | 0 | 123,758 | 42,510 | 28.14% | -81,248 |